Announce Date | 03/17/2025 |
EPS Normalized Actual | $0.58 (Beat by $1.34) |
EPS GAAP Actual | $0.58 (Beat by $1.34) |
Revenue Actual | $0.580365B |
Revenue Surprise | Beat by $580.365M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $-0.58748 |
EPS GAAP Estimate | $-0.58748 |
Revenue Estimate | $0.6737549B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | -1.36 | -8.26 | -1.42002 | -1.2924 | 1 |
Dec 2026 | -0.90222 | -12.45 | -0.90445 | -0.9 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | -1.77 | -1.77 | 0.580365B | 100% | 580.37M |
FQ3 2024 (Sep 2024) | -5.1 | -5.1 | 0.629974B | -0.4% | 629.97M |
FQ2 2024 (Jun 2024) | -1.24 | -1.24 | 0.621657B | 2.49% | 621.66M |
FQ1 2024 (Mar 2024) | -3.61 | -3.61 | 0.618482B | 3.2% | 618.48M |
FQ4 2023 (Dec 2023) | 0 | 0 | 0B | NAN% | 0M |
FQ1 2017 (Mar 2017) | 0.37 | 0.37 | 0.107468B | 100% | 107.47M |
FQ2 2017 (Jun 2017) | 0.37 | 0.37 | 0.107468B | 100% | 107.47M |
FQ3 2017 (Sep 2017) | 0.33 | 0.33 | 0.106562B | 100% | 106.56M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
-0.58748
Consensus Revenue Estimates
0.6737549B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | -0.095458 | -- | -0.095458 | -0.095458 | 1 |
FQ2 2027 (Jun 2027) | -0.11022 | -- | -0.11022 | -0.11022 | 1 |
FQ1 2027 (Mar 2027) | -0.50651 | -- | -0.50651 | -0.50651 | 1 |
FQ4 2026 (Oct 2026) | 0.13791 | -- | 0.1335 | 0.14232 | 1 |
FQ3 2026 (Jul 2026) | -0.090349 | -- | -0.09323963 | -0.08746241 | 1 |
FQ2 2026 (Jun 2026) | -0.13663 | -- | -0.141 | -0.13273 | 1 |
FQ1 2026 (Mar 2026) | -0.2346 | -- | -0.24211 | -0.2279 | 1 |
FQ4 2025 (Oct 2025) | -0.96237 | -83.92 | -0.99316 | -0.93162 | 2 |
FQ3 2025 (Jul 2025) | -1.0531 | -384.28 | -1.08679 | -1.01945 | 2 |
FQ2 2025 (Jun 2025) | -0.58748 | -111.07 | -0.60629 | -0.57071 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0.73B | -- | 0.73B | 0.73B | 2 |
FQ2 2027 (Jun 2027) | 0.71B | -- | 0.71B | 0.71B | 2 |
FQ1 2027 (Mar 2027) | 0.68B | -- | 0.68B | 0.68B | 1 |
FQ4 2026 (Oct 2026) | 0.74B | -- | 0.72B | 0.75B | 4 |
FQ3 2026 (Jul 2026) | 0.71B | -- | 0.69B | 0.73B | 4 |
FQ2 2026 (Jun 2026) | 0.7B | -- | 0.69B | 0.72B | 4 |
FQ1 2026 (Mar 2026) | 0.69B | -- | 0.68B | 0.71B | 4 |
FQ4 2025 (Oct 2025) | 0.69B | 15.97 | 0.67B | 0.71B | 2 |
FQ3 2025 (Jul 2025) | 0.67B | 6.1 | 0.65B | 0.69B | 2 |
FQ2 2025 (Jun 2025) | 0.67B | 7.73 | 0.66B | 0.69B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
4
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
0
Revenue # of in-lines
1
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | -1.77 | -1.77 | 100% | |
FQ3 2024 (Sep 2024) | -5.1 | -5.1 | 100% | |
FQ2 2024 (Jun 2024) | -1.24 | -1.24 | 100% | |
FQ1 2024 (Mar 2024) | -3.61 | -3.61 | 100% | |
FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
FQ1 2017 (Mar 2017) | 0.37 | 0.37 | 100% | |
FQ2 2017 (Jun 2017) | 0.37 | 0.37 | 100% | |
FQ3 2017 (Sep 2017) | 0.33 | 0.33 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $0.58B | $580.37M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.63B | $629.97M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.62B | $621.66M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.62B | $618.48M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0B | $0M | NAN% |
FQ1 2017 (Mar 2017) | $0B | $0.11B | $107.47M | 100% |
FQ2 2017 (Jun 2017) | $0B | $0.11B | $107.47M | 100% |
FQ3 2017 (Sep 2017) | $0B | $0.11B | $106.56M | 100% |